Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
04.08. | Pulsecare gets regulatory nod for nanosecond PFA in China | ||
04.08. | RxSight appoints former Axonics founder, CEO to board | ||
04.08. | TransMedics gets FDA green light to begin next-gen heart perfusion trial | ||
04.08. | Getinge earns reinstated CE mark for intra-aortic balloon pump | ||
04.08. | Synchron debuts BCI-enabled, thought-controlled iPad experience through Apple collab | ||
04.08. | Ypsomed completes sale of diabetes care business to TecMed | ||
01.08. | Boston Scientific earns Medicare reimbursement for Agent drug-coated balloon | ||
01.08. | Carlsmed earns Medicare win for AI-powered spine implants | ||
01.08. | Orchestra BioMed prices $40M offering, amends Medtronic deal | ||
01.08. | Ultromics raises $55M for AI heart failure diagnostics | ||
01.08. | iRhythm inks AI-powered arrhythmia detection partnership with Lucem Health, reports strong Q2 | ||
01.08. | Stryker ups guidance on Street-beating Q2, reduced tariff impact | ||
31.07. | Vicarious Surgical has a new CEO | ||
31.07. | Resmed posts Wall Street beat in Q2 | ||
31.07. | Baxter stock takes a hit on Q2 misses, lowered guidance | ||
31.07. | Integra stock rises on Q2, continued FDA warning letter remediation | ||
31.07. | Sava raises $19M to advance glucose biosensor | ||
31.07. | Diabetes Technology Innovations Special Report | ||
31.07. | InspireMD brings in $58M, adds former Axonics CEO to board | ||
31.07. | EvoEndo earns expanded FDA clearance for gastroscope | ||
31.07. | SetPoint Medical gets FDA nod for neuromod that treats arthritis | ||
30.07. | Dexcom to promote COO Jake Leach to CEO, succeeding Kevin Sayer | ||
30.07. | Siemens Healthineers says tariffs certainty helps revenue outlook | ||
30.07. | Maui Imaging raises $14M Series D for echo tomography tech | ||
30.07. | Fujifilm launches portable digital radiography system |